HomeELYM • NASDAQ
add
Eliem Therapeutics Inc
Previous close
$8.39
Day range
$8.40 - $11.55
Year range
$2.34 - $11.55
Market cap
284.78M USD
Avg Volume
1.70M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.06M | -68.02% |
Net income | -3.64M | 53.09% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 106.80M | -13.57% |
Total assets | 110.47M | -18.17% |
Total liabilities | 2.87M | -54.28% |
Total equity | 107.60M | — |
Shares outstanding | 27.72M | — |
Price to book | 2.16 | — |
Return on assets | -6.84% | — |
Return on capital | -7.00% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.64M | 53.09% |
Cash from operations | -947.00K | 88.79% |
Cash from investing | 36.75M | 157.37% |
Cash from financing | 288.00K | — |
Net change in cash | 35.76M | 367.99% |
Free cash flow | 835.62K | 118.64% |
About
Founded
2018
Headquarters
Website
Employees
10